Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus

K Aaboe, F K Knop, T Vilsbøll, C F Deacon, Jens Juul Holst, S Madsbad, Troels Magelund Krarup

93 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab